244 related articles for article (PubMed ID: 28041327)
21. Filling a cervical spine cage with local autograft: change of bone density and assessment of bony fusion.
Pitzen T; Kiefer R; München D; Barbier D; Reith W; Steudel WI
Zentralbl Neurochir; 2006 Feb; 67(1):8-13. PubMed ID: 16518745
[TBL] [Abstract][Full Text] [Related]
22. Cell based therapies as compared to autologous bone grafts for spinal arthrodesis.
Khashan M; Inoue S; Berven SH
Spine (Phila Pa 1976); 2013 Oct; 38(21):1885-91. PubMed ID: 23873235
[TBL] [Abstract][Full Text] [Related]
23. Use of Bone Morphogenetic Protein-2 in Vertebral Column Tumor Surgery: A National Investigation.
De la Garza Ramos R; Nakhla J; Echt M; Gelfand Y; Altschul DJ; Cho W; Kinon MD; Yassari R
World Neurosurg; 2018 Sep; 117():e17-e21. PubMed ID: 29733987
[TBL] [Abstract][Full Text] [Related]
24. Graft options in posterolateral and posterior interbody lumbar fusion.
Rihn JA; Kirkpatrick K; Albert TJ
Spine (Phila Pa 1976); 2010 Aug; 35(17):1629-39. PubMed ID: 20628336
[TBL] [Abstract][Full Text] [Related]
25. Comparison of bone grafts for posterior spinal fusion in adolescent idiopathic scoliosis.
Price CT; Connolly JF; Carantzas AC; Ilyas I
Spine (Phila Pa 1976); 2003 Apr; 28(8):793-8. PubMed ID: 12698123
[TBL] [Abstract][Full Text] [Related]
26. Bone graft volumetric changes and clinical outcomes after instrumented lumbar or lumbosacral fusion: a prospective cohort study with a five-year follow-up.
Ha KY; Lee JS; Kim KW
Spine (Phila Pa 1976); 2009 Jul; 34(16):1663-8. PubMed ID: 19561561
[TBL] [Abstract][Full Text] [Related]
27. Biological substitutes/extenders for spinal arthrodesis: which agents are cost-effective?
Hsu WK; Hashimoto RE; Berven SH; Nassr A
Spine (Phila Pa 1976); 2014 Oct; 39(22 Suppl 1):S86-98. PubMed ID: 25299264
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in posterolateral lumbar fusion: an open, active-controlled, randomized, multicenter trial.
Cho JH; Lee JH; Yeom JS; Chang BS; Yang JJ; Koo KH; Hwang CJ; Lee KB; Kim HJ; Lee CK; Kim H; Suk KS; Nam WD; Han J
Spine J; 2017 Dec; 17(12):1866-1874. PubMed ID: 28652196
[TBL] [Abstract][Full Text] [Related]
29. A review of demineralized bone matrices for spinal fusion: the evidence for efficacy.
Aghdasi B; Montgomery SR; Daubs MD; Wang JC
Surgeon; 2013 Feb; 11(1):39-48. PubMed ID: 23040457
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of bioabsorbable multiamino acid copolymer/α-tri-calcium phosphate interbody fusion cages in a goat model.
Chunguang Z; Yueming S; Chongqi T; Hong D; Fuxing P; Yonggang Y; Hong L
Spine (Phila Pa 1976); 2011 Dec; 36(25):E1615-22. PubMed ID: 21270683
[TBL] [Abstract][Full Text] [Related]
31. What bone graft substitutes should we use in post-traumatic spinal fusion?
Guerado E; Fuerstenberg CH
Injury; 2011 Sep; 42 Suppl 2():S64-71. PubMed ID: 21839997
[TBL] [Abstract][Full Text] [Related]
32. Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004.
Mummaneni PV; Pan J; Haid RW; Rodts GE
J Neurosurg Spine; 2004 Jul; 1(1):19-23. PubMed ID: 15291015
[TBL] [Abstract][Full Text] [Related]
33. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
[TBL] [Abstract][Full Text] [Related]
34. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study.
Vaccaro AR; Whang PG; Patel T; Phillips FM; Anderson DG; Albert TJ; Hilibrand AS; Brower RS; Kurd MF; Appannagari A; Patel M; Fischgrund JS
Spine J; 2008; 8(3):457-65. PubMed ID: 17588821
[TBL] [Abstract][Full Text] [Related]
35. Use of recombinant human bone morphogenetic protein-2 with local bone graft instead of iliac crest bone graft in posterolateral lumbar spine arthrodesis.
Park DK; Kim SS; Thakur N; Boden SD
Spine (Phila Pa 1976); 2013 May; 38(12):E738-47. PubMed ID: 23474598
[TBL] [Abstract][Full Text] [Related]
36. Vascularized Bone Grafting for Reconstruction of Oncologic Defects in the Spine: A Systematic Review and Pooled Analysis of the Literature.
Pedreira R; Siotos C; Cho BH; Seal SM; Bhat D; Carl HM; Seu M; Wolinksy JP; Sacks JM
J Reconstr Microsurg; 2018 Nov; 34(9):708-718. PubMed ID: 29719912
[TBL] [Abstract][Full Text] [Related]
37. Impact of bone morphogenetic proteins on frequency of revision surgery, use of autograft bone, and total hospital charges in surgery for lumbar degenerative disease: review of the Nationwide Inpatient Sample from 2002 to 2008.
Dagostino PR; Whitmore RG; Smith GA; Maltenfort MG; Ratliff JK
Spine J; 2014 Jan; 14(1):20-30. PubMed ID: 23218827
[TBL] [Abstract][Full Text] [Related]
38. Graft resorption with the use of bone morphogenetic protein: lessons from anterior lumbar interbody fusion using femoral ring allografts and recombinant human bone morphogenetic protein-2.
Pradhan BB; Bae HW; Dawson EG; Patel VV; Delamarter RB
Spine (Phila Pa 1976); 2006 May; 31(10):E277-84. PubMed ID: 16648733
[TBL] [Abstract][Full Text] [Related]
39. A comparative analysis of fusion rates and donor-site morbidity for autogeneic rib and iliac crest bone grafts in posterior cervical fusions.
Sawin PD; Traynelis VC; Menezes AH
J Neurosurg; 1998 Feb; 88(2):255-65. PubMed ID: 9452233
[TBL] [Abstract][Full Text] [Related]
40. Gluteal-sparing approach for posterior iliac crest bone graft: description of a new technique and assessment of morbidity in ninety-two patients after spinal fusion.
Merritt AL; Spinnicke A; Pettigrew K; Alamin TF
Spine (Phila Pa 1976); 2010 Jun; 35(14):1396-400. PubMed ID: 20551786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
